We are live on
!
Find out more
EDRAMF
Edmond de Rothschild Asset Management (France) Portfolio holdings
AUM
$2.3B
1-Year Est. Return
15.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+15.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.71B
AUM Growth
–
Cap. Flow
+$3.68B
Cap. Flow
% of AUM
99.16%
Top 10 Holdings %
Top 10 Hldgs %
26.37%
Holding
211
New
191
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$146M |
| 2 |
Merck
MRK
|
+$116M |
| 3 |
MetLife
MET
|
+$99.9M |
| 4 |
JPMorgan Chase
JPM
|
+$99.5M |
| 5 |
UBS Group
UBS
|
+$98.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.67% |
| 2 | Healthcare | 19.46% |
| 3 | Technology | 13.56% |
| 4 | Industrials | 12.48% |
| 5 | Consumer Discretionary | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
S
51
DELISTED
Sprint Corporation
S
| $27.4M | 0.74% |
+6,019,500
| New | +$29M |
|
52
D.R. Horton
DHI
$41.6B
| $26.7M | 0.72% |
+976,000
| New | +$26.2M |
|
53
Johnson & Johnson
JNJ
$630B
| $26.5M | 0.72% |
+272,400
| New | +$27.3M |
|
|
BGC
54
DELISTED
General Cable Corporation
BGC
| $24.7M | 0.66% |
+1,250,000
| New | +$23.2M |
|
55
Fluor
FLR
$6.89B
| $24.6M | 0.66% |
+463,500
| New | +$26.8M |
|
56
Biogen
BIIB
$31.1B
| $23.9M | 0.64% |
+59,180
| New | +$23.8M |
|
57
ON Semiconductor
ON
$32.6B
| $23.5M | 0.63% |
+2,009,000
| New | +$24.6M |
|
|
CELG
58
DELISTED
Celgene Corp
CELG
| $23.3M | 0.63% |
+201,600
| New | +$23M |
|
59
Micron Technology
MU
$1.09T
| $17.5M | 0.47% |
+931,300
| New | +$24.8M |
|
|
AGN
60
DELISTED
Allergan plc
AGN
| $17.4M | 0.47% |
+57,500
| New | +$17.1M |
|
|
BHI
61
DELISTED
Baker Hughes
BHI
| $17.2M | 0.46% |
+278,100
| New | +$18.2M |
|
62
Amgen
AMGN
$226B
| $16.8M | 0.45% |
+109,600
| New | +$17.6M |
|
|
AET
63
DELISTED
Aetna Inc
AET
| $16.1M | 0.43% |
+126,500
| New | +$14.4M |
|
64
Thermo Fisher Scientific
TMO
$222B
| $15.2M | 0.41% |
+117,000
| New | +$15.3M |
|
65
Wells Fargo
WFC
$266B
| $15.1M | 0.41% |
+269,270
| New | +$15M |
|
66
Revvity
RVTY
$13.1B
| $14.1M | 0.38% |
+266,900
| New | +$13.9M |
|
67
MasTec
MTZ
$23.2B
| $13.4M | 0.36% |
+671,900
| New | +$12.6M |
|
68
Centene
CNC
$32.8B
| $13.3M | 0.36% |
+329,600
| New | +$11.8M |
|
69
Incyte
INCY
$24.5B
| $12.8M | 0.34% |
+122,500
| New | +$12.7M |
|
|
TTM
70
DELISTED
Tata Motors Limited
TTM
| $12.7M | 0.34% |
+367,086
| New | +$14.6M |
|
71
Alphabet (Google) Class C
GOOG
$4.2T
| $12.3M | 0.33% |
+471,100
| New | +$12.6M |
|
72
UnitedHealth
UNH
$361B
| $12M | 0.32% |
+98,500
| New | +$11.7M |
|
73
Ionis Pharmaceuticals
IONS
$9.27B
| $11.6M | 0.31% |
+200,700
| New | +$12.8M |
|
74
Perrigo
PRGO
$1.75B
| $11.2M | 0.3% |
+60,500
| New | +$11.5M |
|
75
Regeneron Pharmaceuticals
REGN
$83.6B
| $10.2M | 0.27% |
+20,000
| New | +$9.76M |
|
Similar funds
PRA
JHC
TH
GF
ACN
GAIA
CCM
BIM
Edmond de Rothschild Asset Management (France)'s Q2 2015 Portfolio in Review
Q2 2015 is the first quarter with a 13F filing on record for Edmond de Rothschild Asset Management (France), which disclosed 211 positions worth $3.71B. Its ten largest holdings account for 26% of the portfolio.
Its largest position is Citigroup: 2,687,940 shares worth $148M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, followed by Healthcare and Technology.
- Edmond de Rothschild Asset Management (France)'s largest Q2 2015 buy was Citigroup: 2,687,940 shares worth $148M.
- Edmond de Rothschild Asset Management (France)'s ten largest holdings make up 26% of its $3.71B portfolio in Q2 2015.
- Edmond de Rothschild Asset Management (France) disclosed 211 positions in Q2 2015, its first 13F filing on record.
Based on Edmond de Rothschild Asset Management (France)'s 13F filing for Q2 2015, filed 7 Aug 2015.